Key Players
Competitive Landscape
Four business models shape competition in acrylamide mitigation systems: dedicated enzyme developers, diversified food-bioscience groups, bakery formulation specialists and application-service networks. Industrial bakery teams compare reduction data beside texture and throughput since a mitigation enzyme must survive the customer's own recipe. Companies with regional baking laboratories can reproduce line conditions earlier and shorten the work needed ahead of commercial release.
Investment moved toward application infrastructure in 2025 as reformulation demands broadened beyond single-ingredient performance. Novonesis launched Optiva LS Prime in June 2025 for reduced-sugar bakery formulations. dsm-firmenich opened the Van Marken Food Innovation Center in October 2025 with dedicated bakery laboratories in Delft. Those investments strengthen customer-side formulation proof and reduce the plant time committed to broader recipe changes.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In May 2026, AB Enzymes expanded its distribution network in Mexico, Central America and the Caribbean. | Bakeries need closer technical contact before enzyme programs can be adapted to local flour and process conditions. | Enzyme companies are widening regional service networks instead of relying only on centralized technical teams. | Regional distributors can carry bakery trial support into accounts that are too small for direct global coverage. |
| In October 2025, Palsgaard began producing Emulpals powdered cake emulsifiers in Brazil. | Regional bakery customers value shorter supply routes for powdered formulation ingredients used in repeat production. | Bakery formulation companies are placing more production capacity near growth markets with established industrial customers. | Local dry-ingredient production gives Palsgaard a route to bundle formulation support with faster regional replenishment. |
| In June 2026, Puratos opened its Flour Competence Center in Belgium for flour analysis and application guidance. | Flour variability changes dough behavior and complicates repeat qualification of enzyme-based bakery programs. | Application support is expanding upstream into flour characterization before recipe changes reach a production line. | Mitigation programs can be tested beside flour-quality changes so bakeries avoid treating acrylamide control as an isolated reformulation task. |
Novonesis, Kerry Group, dsm-firmenich, IFF and Corbion compete outside the three mapped developments with enzyme platforms and bakery laboratories that extend customer testing capacity.
Source: Future Market Insights, Acrylamide Mitigation Systems Market and Baking Enzymes Market Reports, 2026-2036.
The eight companies collectively span enzyme development and bakery application testing plus regional technical support for qualification under commercial production conditions.
Who leads the acrylamide mitigation systems market?
Novonesis and Kerry Group have the clearest enzyme-led positions. dsm-firmenich and IFF broaden competition through larger bakery bioscience and application networks.
Which suppliers have documented qualification or quality approvals?
Food-enzyme approval applies to individual enzymes and jurisdictions, so company-wide portfolios cannot substitute for product-level authorization and manufacturing evidence during customer qualification.
Which companies provide bakery application products?
dsm-firmenich, IFF, AB Enzymes, Palsgaard, Corbion and Puratos document current bakery laboratories, product launches or formulation programs that support commercial bakery development.
Which suppliers serve North America and Europe?
Novonesis, Kerry Group, dsm-firmenich, IFF, Corbion and Puratos maintain operating or application networks that serve both North American and European food customers.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Novonesis | Global biosolutions producer with bakery enzyme platforms and formulation support. | In June 2025, launched Optiva LS Prime for reduced-sugar baked goods with stated reductions of up to 50% added sugar. |
| Kerry Group | Global taste and nutrition group with food enzymes plus biotechnology development and manufacturing. | In April 2026, opened an expanded biotechnology manufacturing facility in Carrigaline that increased industrial enzyme production capacity. |
| dsm-firmenich | Global food-ingredient group with bakery laboratories, enzymes and formulation services. | In October 2025, opened the Van Marken Food Innovation Center in Delft with dedicated bakery application facilities. |
| IFF | Global food bioscience group serving bakery through enzymes, ingredients and regional innovation centers. | In July 2025, expanded its Singapore Innovation Center with an Immersive Experience Hub for customer-side concept testing. |
| AB Enzymes | Enzyme specialist with bakery laboratories and regional distribution partners. | In May 2026, expanded distribution coverage in Mexico, Central America and the Caribbean for food and baking applications. |
| Palsgaard | Emulsifier and stabilizer specialist with industrial bakery pilot and application facilities. | In October 2025, started Brazilian production of Emulpals powdered cake emulsifiers for regional and global demand. |
| Corbion | Bakery formulation and preservation specialist serving commercial baking customers. | In April 2025, launched Verdad Essence WH100 cultured-wheat mold inhibition for breads, buns, tortillas and flatbreads. |
| Puratos | Global bakery ingredient and application specialist serving industrial and artisan customers. | In June 2026, opened the Flour Competence Center in Belgium for flour analysis, variability research and application guidance. |
Research Methodology
The companies mapped here illustrate the market structure rather than an exhaustive ranking. Inclusion requires current, verifiable evidence that a company supplies acrylamide-mitigation enzymes, bakery enzyme systems or formulation services used in the defined bakery and snack scope. Evidence comes from regulatory approvals, third-party certifications, company announcements, product documentation and public filings. Capabilities are attributed to the stated enzyme platform, bakery formulation portfolio or application service line rather than generalized across broader corporate portfolios. Market-share estimates remain proprietary FMI assessments for the forecast period.
